Adenovirus vector-induced immune responses in nonhuman primates: Responses to prime boost regimens

Journal of Immunology

Volumn 182, Issue 10, 2009, Pages 6587-6599

  Tatsis, Nia ^a   Lasaro, Marcio O ^a   Lin, Shih Wen ^a,b   Xiang, Zhi Q ^a   Zhou, Dongming ^a   Dimenna, Lauren ^a   Li, Hua ^a   Bian, Ang ^a   Abdulla, Sarah ^a   Li, Yan ^a   Giles Davis, Wynetta ^a   Engram, Jessica ^c   Ratcliffe, Sarah J ^c   Silvestri, Guido ^c   Ertl, Hildegund C ^a   Betts, Michael R ^b  

^a WISTAR INSTITUTE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c Department of Pathology and Laboratory Medicine ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CHIMPANZEE; CONTROLLED STUDY; DOSAGE SCHEDULE COMPARISON; DRUG DOSE REGIMEN; DRUG EFFICACY; FEMALE; HUMAN ADENOVIRUS 5; IMMUNE RESPONSE; IMMUNIZATION; MACACA; MALE; NONHUMAN; PRIMATE; PRIORITY JOURNAL; SEROTYPE; T LYMPHOCYTE; VACCINATION;

ADENOVIRIDAE; AIDS VACCINES; ANIMALS; ANTIBODIES, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENETIC VECTORS; HUMAN IMMUNODEFICIENCY VIRUS PROTEINS; IMMUNIZATION, SECONDARY; INTERFERON-GAMMA; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MACACA MULATTA; PAN TROGLODYTES; POLYMERASE CHAIN REACTION; T-LYMPHOCYTES;

EID: 68249108510     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0900317     Document Type: Article

References (38)

1. Robinson, H. L. 2007. HIV/AIDS vaccines: 2007. Clin. Pharmacol. Ther. 82: 686-693.
2. Steinbrook, R. 2007. One step forward, two steps back: will there ever be an AIDS vaccine? N. Engl. J. Med. 357: 2653-2655.
3. Hanke, T. 2008. STEP trial and HIV-1 vaccines inducing T-cell responses. Expert Rev. Vaccines 7: 303-309. (Pubitemid 351520018)
4. Watkins, D. I., D. R. Burton, E. G. Kallas, J. P. Moore, and W. C. Koff. 2008. Nonhuman primate models and the failure of the Merck HIV-1 vaccine in humans. Nat. Med. 14: 617-621.
5. Moore, J. P., P. J. Klasse, M. J. Dolan, and S. K. Ahuja. 2008. AIDS/HIV. A STEP into darkness or light? Science 320: 753-755.
6. Zahradnik, J. M. 1987. Adenovirus pneumonia. Semin. Respir. Infect. 2: 104-111.
7. Fitzgerald, J. C., G. P. Gao, A. Reyes-Sandoval, G. N. Pavlakis, Z. Q. Xiang, A. P. Wlazlo, W. Giles-Davis, J. M. Wilson, and H. C. Ertl. 2003. A simian replication-defective adenoviral recombinant vaccine to HIV-1 gag. J. Immunol. 170: 1416-1422.
8. + T cells to an HIV-1 antigen through a prime boost regimen with heterologous E1-deleted adenoviral vaccine carriers. J. Immunol. 171: 6774-6779.
9. Farina, S. F., G. P. Gao, Z. Q. Xiang, J. J. Rux, R. M. Burnett, M. R. Alvira, J. Marsh, H. C. Ertl, and J. M. Wilson. 2001. Replication-defective vector based on a chimpanzee adenovirus. J. Virol. 75: 11603-11613.
10. Cohen, C. J., Z. Q. Xiang, G. P. Gao, H. C. Ertl, J. M. Wilson, and J. M. Bergelson. 2002. Chimpanzee adenovirus CV-68 adapted as a gene delivery vector interacts with the coxsackievirus and adenovirus receptor. J. Gen. Virol. 83: 151-155.
11. Reyes-Sandoval, A., J. C. Fitzgerald, R. Grant, S. Roy, Z. Q. Xiang, Y. Li, G. P. Gao, J. M. Wilson, and H. C. Ertl. 2004. Human immunodeficiency virus type 1-specific immune responses in primates upon sequential immunization with adenoviral vaccine carriers of human and simian serotypes. J. Virol. 78: 7392-7399. (Pubitemid 38915884)
12. Xiang, Z., Y. Li, A. Cun, W. Yang, S. Ellenberg, W. M. Switzer, M. L. Kalish, and H. C. Ertl. 2006. Chimpanzee adenovirus antibodies in humans, sub-Saharan Africa. Emerg. Infect. Dis. 12: 1596-1599. (Pubitemid 44570909)
13. McCoy, K., N. Tatsis, B. Korioth-Schmitz, M. O. Lasaro, S. E. Hensley, S. W. Lin, Y. Li, W. Giles-Davis, A. Cun, D. Zhou, et al. 2007. Effect of preexisting immunity to adenovirus human serotype 5 antigens on the immune responses of nonhuman primates to vaccine regimens based on human- or chimpanzee-derived adenovirus vectors. J. Virol. 81: 6594-6604. (Pubitemid 46878063)
14. + T cells: implications for their use as vaccines. Blood 110: 1916-1923.
15. Haynes, B. F., and D. C. Montefiori. 2006. Aiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidates. Expert Rev. Vaccines 5: 579-595. (Pubitemid 44627888)
16. Burton, D. R., R. L. Stanfield, and I. A. Wilson. 2005. Antibody vs. HIV in a clash of evolutionary titans. Proc. Natl. Acad. Sci. USA 102: 14943-14948.
17. Shiver, J. W., and E. A. Emini. 2004. Recent advances in the development of HIV-1 vaccines using replication-incompetent adenovirus vectors. Annu. Rev. Med. 55: 355-372.
18. McMichael, A. J. 2006. HIV vaccines. Annu. Rev. Immunol. 24: 227-255.
19. Robinson, H. L. 2002. New hope for an AIDS vaccine. Nat. Rev. Immunol. 2: 239-250.
20. + central memory T cells and survival in vaccinated SIV-challenged monkeys. Science 312: 1530-1533.
21. + T cell induction, is dependent on type I IFN signaling during vaccination with adenovirus vectors. J. Immunol. 175: 6032-6041.
22. Varnavski, A. N., K. Schlienger, J. M. Bergelson, G. P. Gao, and J. M. Wilson. 2003. Efficient transduction of human monocyte-derived dendritic cells by chimpanzee-derived adenoviral vector. Hum. Gene Ther. 14: 533-544. (Pubitemid 36438938)
23. + T cells. Blood 107: 4781-4789.
24. Betts, M. R., B. Exley, D. A. Price, A. Bansal, Z. T. Camacho, V. Teaberry, S. M. West, D. R. Ambrozak, G. Tomaras, M. Roederer, et al. 2005. Characterization of functional and phenotypic changes in anti-Gag vaccine-induced T cell responses and their role in protection after HIV-1 infection. Proc. Natl. Acad. Sci. USA 102: 4512-4517.
25. Masopust, D., S. J. Ha, V. Vezys, and R. Ahmed. 2006. Stimulation history dictates memory CD8 T cell phenotype: implications for prime-boost vaccination. J. Immunol. 177: 831-839.
26. + T cell functionality and mucosal homing. Virology 367: 156-167.
27. Pitcher, C. J., S. I. Hagen, J. M. Walker, R. Lum, B. L. Mitchell, V. C. Maino, M. K. Axthelm, and L. J. Picker. 2002. Development and homeostasis of T cell memory in rhesus macaque. J. Immunol. 168: 29-43.
28. Benedict, C. A., P. S. Norris, T. I. Prigozy, J. L. Bodmer, J. A. Mahr, C. T. Garnett, F. Martinon, J. Tschopp, L. R. Gooding, and C. F. Ware. 2001. Three adenovirus E3 proteins cooperate to evade apoptosis by tumor necrosis factor-related apoptosis-inducing ligand receptor-1 and -2. J. Biol. Chem. 276: 3270-3278. (Pubitemid 37411621)
29. McNees, A. L., C. T. Garnett, and L. R. Gooding. 2002. The adenovirus E3 RID complex protects some cultured human T and B lymphocytes from Fas-induced apoptosis. J. Virol. 76: 9716-9723.
30. + T cell depletion in simian immunodeficiency virusinfected macaques. J. Exp. Med. 189: 991-998.
31. + T cell responses. Virology 353: 83-98.
32. Liu, J., K. L. O'Brien, D. M. Lynch, N. L. Simmons, A. La Porte, A. M. Riggs, P. Abbink, R. T. Coffey, L. E. Grandpre, M. S. Seaman, et al. 2009. Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys. Nature 457: 87-91.
33. + T cells mediate protection of rhesus macaques immunized with attenuated simian-human immunodeficiency virus SHIV89.6 from vaginal challenge with simian immunodeficiency virus. J. Virol. 82: 11181-11196.
34. + CD4 T cell responses is associated with nonprogression in HIV-1 infection. J. Immunol. 169: 6376-6385.
35. + T cells and associated with a proliferative response to p24 antigen. J. Virol. 74: 2023-2028.
36. Feeney, M. E., Y. Tang, K. A. Roosevelt, A. J. Leslie, K. McIntosh, N. Karthas, B. D. Walker, and P. J. Goulder. 2004. Immune escape precedes breakthrough human immunodeficiency virus type 1 viremia and broadening of the cytotoxic T-lymphocyte response in an HLA-B27-positive long-term-nonprogressing child. J. Virol. 78: 8927-8930.
37. McElrath, M. J., S. C. De Rosa, Z. Moodie, S. Dubey, L. Kierstead, H. Janes, O. D. Defawe, D. K. Carter, J. Hural, R. Akondy, et al; Step Study Protocol Team. 2008. HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis. Lancet 372: 1894-1905.
38. Buchbinder, S. P., D. V. Mehrotra, A. Duerr, D. W. Fitzgerald, R. Mogg, D. Li, P. B. Gilbert, J. R. Lama, M. Marmor, C. Del Rio, et al; Step Study Protocol Team. 2008. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial. Lancet 372: 1881-1893.